Front Line Medical Technologies, has announced that its COBRA-OS (Control Of Bleeding, Resuscitation, Arterial Occlusion System) has officially been granted CE marking under the new European Medical Device Regulations.
Front Line
EU medical providers now have full access to this aortic occlusion device, the first of its kind to be approved through the new MDR system.
“The CE marking of the COBRA-OS is momentous for our company, as it reinforces our dedication to technological excellence and our unwavering commitment to better patient care,” said Dr. Asha Parekh, CEO of Front Line Medical Technologies. “Day in and day out, our pursuit of helping to save as many lives as we can is what drives our entire team, and this regulatory achievement means we are further on our way to accomplishing that goal.”
The COBRA-OS is most notable for its ultra-low profile. It also doesn’t require an over-the-wire technique, which speeds up deployment and buys valuable time until definitive care can be provided and is accompanied by a 4 French mini-access sheath kit and a 10 cc sword-handled syringe.